Alvotech (ALVO) Cash & Equivalents (2020 - 2025)
Alvotech filings provide 6 years of Cash & Equivalents readings, the most recent being $172.4 million for Q4 2025.
- On a quarterly basis, Cash & Equivalents rose 235.15% to $172.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $172.4 million, a 235.15% increase, with the full-year FY2025 number at $172.4 million, up 1444.85% from a year prior.
- Cash & Equivalents hit $172.4 million in Q4 2025 for Alvotech, up from $51.4 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $172.4 million in Q4 2025 to a low of $10.9 million in Q2 2024.
- Median Cash & Equivalents over the past 5 years was $55.9 million (2023), compared with a mean of $69.4 million.
- Biggest five-year swings in Cash & Equivalents: tumbled 83.2% in 2023 and later surged 369.92% in 2025.
- Alvotech's Cash & Equivalents stood at $17.6 million in 2021, then surged by 278.37% to $66.4 million in 2022, then tumbled by 83.2% to $11.2 million in 2023, then skyrocketed by 360.95% to $51.4 million in 2024, then surged by 235.15% to $172.4 million in 2025.
- The last three reported values for Cash & Equivalents were $172.4 million (Q4 2025), $51.4 million (Q3 2025), and $51.4 million (Q2 2025) per Business Quant data.